Cholesterol API Market Insights, Research and Growth Factor till 2032
The Global Cholesterol API Market is estimated to be valued at US$ 269.0 Million by the end of 2022, and to grow at a CAGR of 4.7% between 2022 and 2032. By 2032, the global cholesterol API market is expected to be worth US$ 426.9 million. Animal-derived sources are the market leaders, accounting for approximately 52.7% of the market in 2021. Liposomes are a very important part of any drug delivery system with many beneficial properties such as easy preparation, bilayer structure assembling the cellular membrane, and high biocompatibility. Extensive efforts have been dedicated to the use of cholesterol in liposome-based formulations. Cholesterol, being an integral part of any biological membrane, plays a significant role in liposomal formulations. Liposomes with higher cholesterol content are highly stable. According to a study by Ascension Sciences published in December 2020, parameters like stability, size, and encapsulation efficiency are used during liposome formulation. Stability...